Ma et al.
(m, 2H), 1.76 (s, 3H), 1.70 (s, 3H); EI-MS m/z 144 (M+), 129,
120, 111, 101, 68, 41; HRMS found m/z 144.0721 (M+),
C6H12N2S requires 144.0721.
A solution of 21 (3.3 g, 22.9 mmol) and CH3I (2.85 mL, 45.8
mmol) in 20 mL of anhydrous DMF was stirred at room
temperature overnight. The solvent was removed in vacuo to
give 6 g of a crude of 24.
anhydrous trifluoroacetic acid were added. The mixture was
stirred at room temperature for 14 h and then concentrated.
The residue was purified by reversed phase column chroma-
tography (C18 silica gel) eluting with 8/1 to 2/1 water/methanol
to give 15 mg of 1 in 65% yield as its trifluoroacetic salt: [R]20
D
-122.7 (c 0.31, MeOH); 1H NMR (400 MHz, CDCl3) δ 7.65 (s,
1H), 7.55 (d, J ) 8.5 Hz, 1H), 6.59 (d, J ) 8.5 Hz, 1H), 5.34 (t,
J ) 6.6 Hz, 1H), 5.31 (d, J ) 6.5 Hz, 1H), 5.18 (t, J ) 6.8 Hz,
1H), 3.97 (dd, J ) 15.3, 6.5 Hz, 1H), 3.87 (dd, J ) 15.3, 6.3
Hz, 1H), 3.74 (d, J ) 6.6 Hz, 2H), 3.39 (m, 2H), 3.28(m, 1H),
3.14 (m, 2H), 2.45 (m, 1H), 2.08(m, 1H), 1.74 (s, 3H), 1.70 (s,
3H), 1.69 (s, 3H), 1.64 (s, 3H),1.69-1.63 (m, 2H), 1.56-1.45
(m, 3H); 13C NMR (400 MHz, CDCl3) δ 167.2, 155.5, 154.3,
146.4, 136.1, 135.7, 130.5, 130.1, 119.6, 119.2, 117.1, 115.8,
113.3, 53.1, 49.1, 45.7, 40.7, 39.7, 39.2, 38.8, 33.4, 26.3, 25.5,
25.4, 25.2, 18.0, 17.9; ESI-MS m/z 724 (M+ + H+ + 2CF3-
COOH), 610 (M+ + H+ + CF3COOH), 496 (M+ + H+), 428.
3-Ben zyl-1-(ter t-b u t yloxyca r b on yl)-2-m et h ylisot h io-
u r ea 31. Following the procedure for synthesizing 26 from
3-methyl-but-2-enylamine, compound 31 was prepared from
To a solution of above crude product, Et3N (6.73 mL, 48.3
mmol), and catalytic DMAP in 20 mL of anhydrous CH2Cl2
was added (Boc)2O (5.52 g, 25.3 mmol). After the mixture was
stirred at room temperature for 4 h, it was washed by water
and brine. The organic layer was dried and concentrated. The
residue was purified by column chromatography eluting with
30/1 chloroform/methanol to give 5.27 g of 26 in 89% yield for
two steps: IR (KBr) 3244, 1637 cm-1 1H NMR (300 MHz,
;
CDCl3) δ 9.64 (br s, 1H), 5.23 (t, J ) 7.0 Hz, 1H), 3.88 (m,
2H), 2.47 (s, 3H), 1.74 (s, 3H), 1.68 (s, 3H), 1.50 (s, 9H); EI-
MS m/z 259 (M+ + H+), 203, 185, 169, 159, 137, 117, 69, 57,
41; HRMS found m/z 258.1429 (M+), C12H22N2SO2 requires
258.1402.
benzylamine in 89% yield: IR (KBr) 3238, 1721, 1647 cm-1
;
(2′S)-N1-Ben zyl-N2-(ter t-bu toxyca r bon yl)-1′-[2′-(d ip h e-
n ylm eth yl)p yr r olid in e]ca r boxa m id in e 29. To a solution
of 26 (23 mg, 0.089 mmol), 28 (23 mg, 0.097 mmol), and Et3N
(14 µL, 0.10 mmol) in 2 mL of anhydrous MeCN was added a
solution of AgNO3 (16 mg, 0.094 mmol) in 0.5 mL of MeCN in
30 min. After the mixture was stirred overnight in the dark,
the resultant precipitate was filtered off and the filtrate was
concentrated to dryness. The residue was dissolved in 10 mL
of CHCl3 and then washed with water and brine. The organic
layer was dried and concentrated. The residue was purified
by column chromatography eluting with 20/1 chloroform/
methanol to give 33 mg (84%) of 29: IR (KBr) 3275, 1633, 1581
1H NMR (300 MHz, CDCl3) δ 10.2 (br s, 1H), 7.35 (m, 5H),
4.52 (d, J ) 5.7 Hz, 2H), 2.48 (s, 3H), 1.51 (s, 9H); EI-MS m/z
280 (M+), 252, 224, 209, 158, 91; HRMS found m/z 280.1216
(M+), C14H20N2O2S requires 280.1246.
Gen er a l P r oced u r e of AgNO3-P r om oted Gu a n yla tion
fr om 31. To a solution of compound 31 (1.0 mmol), amine (1.0
mmol), and Et3N (2.0 mmol) in 5 mL of anhydrous MeCN was
added a solution of AgNO3 (1.5 mmol) in 1 mL of MeCN over
30 min. After the mixture was stirred for 4 h in the dark, the
resultant precipitate was filtered and the filtrate was concen-
trated to dryness. The residue was dissolved by 10 mL of
CHCl3 and then washed with water and brine. After the
solution was dried and concentrated, the residue was purified
by column chromatography eluting with 10/1 to 30/1 chloroform/
methanol to give the corresponding guanylation product.
N1-Ben zyl-N2-(ter t-bu toxyca r bon yl)-4′-m or p h olin eca r -
1
cm-1; H NMR (300 MHz, CDCl3) δ 7.33-7.14 (m, 10H), 5.31
(m, 1H), 5.03 (t, J ) 8.1 Hz, 1H), 4.16 (d, J ) 8.4 Hz, 2H),
3.60 (m, 1H), 3.37 (m, 2H), 2.08 (m, 2H), 1.77 (m, 2H), 1.61 (s,
3H), 1.54 (s, 3H), 1.47 (s, 9H); EI-MS m/z 447 (M+), 390, 373,
346, 236, 224, 206, 165, 138, 70; HRMS found m/z 447.2894
(M+), C28H37N3O2 requires 447.2886.
boxa n id in e 32: 99% yield; IR (KBr) 3183, 3090, 1662 cm-1
;
1H NMR (300 MHz, CDCl3) δ 8.9 (br s, 1H), 7.30 (m, 5H), 4.39
(s, 2H), 3.69 (d, J ) 4.8 Hz, 4H), 3.39 (d, J ) 4.9 Hz, 4H), 1.50
(s, 9H); EI-MS m/z 319 (M+), 264, 247, 219, 188, 158, 133, 106,
91; HRMS found m/z 264.1356 (M+ - But + H+), C13H18N3O3
requires 264.1348.
Com p ou n d 30. To a solution of 3 (62 mg, 0.16 mmol), 26
(200 mg, 0.78 mmol), and Et3N (0.26 mL, 1.87 mmol) in MeCN
(2 mL) and MeOH (1 mL) was added dropwise a solution of
AgNO3 (185 mg, 1.09 mmol) in 0.5 mL of MeCN over a 0.5 h
period. After the reaction mixture was stirred overnight in the
dark, it was filtered and the filtrate was concentrated to
dryness. The residue was partitioned between water and
chloroform. The organic layer was separated and the aqueous
layer was extracted with chloroform. The combined extracts
were dried and concentrated. The residue was purified by
column chromatography eluting with 30/1 chloroform/metha-
nol to give 68 mg (65%) of 30: [R]20D -94.2 (c 0.28, CHCl3); 1H
NMR (300 MHz, CDCl3) δ 7.99 (s, 1H), 7.67 (d, J ) 8.4 Hz,
1H), 6.62 (m, 1H), 5.71 (m, 1H), 5.29 (m, 1H), 5.20 (m, 1H),
3.81 (s, 3H), 3.75 (m, 1H), 3.40-3.32 (m, 6H), 3.12 (m, 1H),
2.34-2.27 (m, 3H), 2.06 (m, 2H), 1.73 (s, 3H), 1.72 (s, 3H), 1.67
(s, 3H), 1.66 (s, 3H), 1.59-1.45 (m, 4H), 1.52 (s, 9H), 1.49 (s,
9H); 13C NMR (150.9 MHz, CDCl3) δ 167.4, 163.8, 160.1, 159.8,
146.5, 142.2, 137.1, 131.7, 130.0, 120.3, 119.6, 118.2, 113.8,
112.8, 78.1, 53.4, 51.4, 50.6, 46.7, 46.4, 42.7, 42.5, 42.0, 40.1,
39.5, 39.4, 38.0, 37.0, 29.6, 28.5, 28.4, 28.0, 27.9, 25.6, 22.1,
17.9, 14.0, 13.2; ESIMS m/z 733 (M+ + Na+), 711 (M+ + H+),
610 (M+ - Boc); HRMS found m/z 710.4600 (M+ + H+),
1-Be n zyl-2-(t er t -b u t oxyca r b on yl)-3,3-d ie t h ylgu a n i-
d in e 33: 98% yield; IR (KBr) 3174, 3030, 1663 cm-1; 1H NMR
(300 MHz, CDCl3) δ 7.34 (m, 5H), 6.80 (br s, 1H), 4.39 (s, 2H),
3.67 (q, J ) 7.1 Hz, 4H), 1.51 (s, 9H), 1.15 (t, J ) 7.2 Hz, 6H);
EI-MS m/z 305 (M+), 249, 232, 205, 176, 106, 91; HRMS found
m/z 249.1491 (M+ - But + H+), C13H19N3O2 requires 249.1477.
N1-Ben zyl-N2-(ter t-bu toxyca r bon yl)-1′-p yr r olid in eca r -
boxa m id in e 34: 98% yield; IR (KBr) 3200, 3088, 1647 cm-1
;
1H NMR (300 MHz, CDCl3) δ 7.32 (m, 5H), 6.95 (br s, 1H),
4.45 (s, 2H), 3.42 (m, 4H), 1.87 (m, 4H), 1.50 (s, 9H); EI-MS
m/z 303 (M+), 247, 230, 146, 106, 91, 70, 57; HRMS found m/z
303.1901 (M+), C17H25N3O2 requires 303.1947.
1-Ben zyl-2-(ter t-bu toxycar bon yl)-3,3-diisopr opylgu an i-
1
d in e 35: 96% yield; IR (KBr) 3271, 1616 cm-1; H NMR (300
MHz, CDCl3) δ 7.39 (m, 5H), 5.00 (br s, 1H), 4.42 (s, 2H), 4.11
(m, 2H), 1.55 (s, 9H), 1.28 (d, J ) 6.3 Hz, 12H); EI-MS m/z
333 (M+), 290, 260, 234, 190, 106, 100, 91, 57; HRMS found
m/z 333.2413 (M+), C19H31N3O2 requires 333.2416.
C
38H59N7O6 requires 710.4605.
1-Ben zyl-2-(ter t-bu toxycar bon yl)-3,3-dicycloh exylgu an i-
1
d in e 36: 91% yield; IR (KBr) 3298, 1644 cm-1; H NMR (300
Ma r tin ellic Acid 1. To a solution of 30 (21 mg, 0.03 mmol)
MHz, CDCl3) δ 7.34 (m, 5H), 5.20 (br s, 1H), 4.37 (s, 2H), 3.51
(m, 2H), 1.76 (m, 8H), 1.62 (m, 6H), 1.51 (s, 9H), 1.27 (m, 4H),
0.98 (m, 2H); EI-MS m/z 413 (M+), 340, 274, 219, 182, 138,
91, 57; HRMS found m/z 413.3023 (M+), C25H39N3O2 requires
413.3042.
in MeOH (3 mL) and water (1 mL) was added NaOH (6 ng,
0.15 mmol). The suspension was refluxed for 10 h and then
neutralized with 0.1 N HCl cautiously. MeOH was removed
under reduced pressure and the aqueous was extracted with
CHCl3. The combined organic layers were dried and concen-
trated. The residue was purified by column chromatography
eluting with 5/1 chloroform/methanol to give 19 mg of the
corresponding acid. This acid was dissolved in 2 mL of
anhydrous CH2Cl2 before 0.05 mL of anisole and 0.1 mL of
(1′R)-1,3-Dib en zyl-2-(ter t-b u t oxyca r b on yl)-3-(1′-p h e-
n yleth yl)gu a n id in e 37: 93% yield; IR (KBr) 3235, 3089, 1641
1
cm-1; H NMR (300 MHz, CDCl3) δ 7.37-7.13 (m, 13H), 6.83
(m, 2H), 5.88 (q, J ) 7.1 Hz, 1H), 5.40 (br s, 1H), 4.31 (s, 2H),
450 J . Org. Chem., Vol. 68, No. 2, 2003